AU576477B2 - 5-fluoro-carbacyclins - Google Patents

5-fluoro-carbacyclins

Info

Publication number
AU576477B2
AU576477B2 AU19804/83A AU1980483A AU576477B2 AU 576477 B2 AU576477 B2 AU 576477B2 AU 19804/83 A AU19804/83 A AU 19804/83A AU 1980483 A AU1980483 A AU 1980483A AU 576477 B2 AU576477 B2 AU 576477B2
Authority
AU
Australia
Prior art keywords
group
denotes
image
radical
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19804/83A
Other versions
AU1980483A (en
Inventor
Martin Haberey
Bernd Raduchel
Werner Skuballa
Claus-Steffen Sturzebecher
Michael-Harold Town
Helmut Vorbruggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU1980483A publication Critical patent/AU1980483A/en
Application granted granted Critical
Publication of AU576477B2 publication Critical patent/AU576477B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins

Abstract

5-Fluorocarbacyclin derivatives of the general formula I <IMAGE> in which R1 denotes the radical CH2OH or <IMAGE> with R2 denoting a hydrogen atom, an alkyl radical, cycloalkyl, aryl, or a <IMAGE> or heterocyclic radical or R1 denotes the radical <IMAGE> with R3 denoting an alkanoyl or alkanesulphonyl radical each having 1-10 C atoms or the radical R2 or R1 denotes the radical <IMAGE> in which m denotes the number 1 or 2, A denotes a -CH2-CH2-, a trans-CH=CH- or -C IDENTICAL C- group, W denotes a free or functionally modified hydroxymethylene group or a free or functionally modified <IMAGE> it being possible for the OH group to be in the alpha - or beta -position, D denotes the group <IMAGE> a straight-chain saturated alkylene group having 1-5 C atoms, a branched saturated or a straight-chain or branched unsaturated alkylene group having 2-5 C atoms, which can optionally be substituted by fluorine atoms, n may denote the number 1, 2 or 3, E represents a direct bond, a -C IDENTICAL C- group or a -CR6=CR7- group, R6 denoting a hydrogen atom or an alkyl group having 1-5 C atoms and R7 denoting a hydrogen atom, a halogen atom or an alkyl group having 1-5 C atoms, R4 denotes an alkyl, cycloalkyl or an optionally substituted aryl group or a heterocyclic group, R5 denotes a free or functionally modified hydroxyl group, and if R2 has the meaning of a hydrogen atom, their salts with physiologically tolerable bases, process for their preparation and their pharmaceutical use.
AU19804/83A 1982-10-05 1983-09-30 5-fluoro-carbacyclins Ceased AU576477B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823237200 DE3237200A1 (en) 1982-10-05 1982-10-05 5-FLUORCARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE3237200 1982-10-05

Publications (2)

Publication Number Publication Date
AU1980483A AU1980483A (en) 1984-04-12
AU576477B2 true AU576477B2 (en) 1988-09-01

Family

ID=6175192

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19804/83A Ceased AU576477B2 (en) 1982-10-05 1983-09-30 5-fluoro-carbacyclins

Country Status (11)

Country Link
EP (1) EP0113311B1 (en)
JP (1) JPS59134739A (en)
AT (1) ATE71087T1 (en)
AU (1) AU576477B2 (en)
CA (1) CA1250834A (en)
DE (2) DE3237200A1 (en)
DK (1) DK459783A (en)
ES (1) ES526227A0 (en)
GR (1) GR78728B (en)
HU (1) HU191111B (en)
ZA (1) ZA837452B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971987A (en) * 1984-07-27 1990-11-20 Schering Aktiengesellschaft New carbacycline, process for their production and their use as a drug
DE102004021319B4 (en) * 2004-04-30 2010-11-11 Siemens Ag Setup of multihop communication connections depending on limit values

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU542861B2 (en) * 1980-02-28 1985-03-21 Pharmacia & Upjohn Company Carbacyclin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338457A (en) * 1980-02-28 1982-07-06 The Upjohn Company Composition and process
DE3104044A1 (en) * 1981-02-02 1982-08-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen NEW PROSTACYCLIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU542861B2 (en) * 1980-02-28 1985-03-21 Pharmacia & Upjohn Company Carbacyclin analogs

Also Published As

Publication number Publication date
JPS59134739A (en) 1984-08-02
DK459783D0 (en) 1983-10-05
ZA837452B (en) 1984-06-27
HU191111B (en) 1987-01-28
DE3382489D1 (en) 1992-02-13
ATE71087T1 (en) 1992-01-15
CA1250834A (en) 1989-03-07
DK459783A (en) 1984-04-06
ES8405355A1 (en) 1984-06-16
DE3237200A1 (en) 1984-04-05
JPH0510330B2 (en) 1993-02-09
EP0113311A1 (en) 1984-07-11
ES526227A0 (en) 1984-06-16
AU1980483A (en) 1984-04-12
EP0113311B1 (en) 1992-01-02
GR78728B (en) 1984-10-02

Similar Documents

Publication Publication Date Title
EP0069696A3 (en) Derivatives of 9-fluoroprostaglandin, process for their preparation and their use as medicaments
GR78873B (en)
AU582712B2 (en) Polymerizable carbamoyloxyalkyldicarboxylic acid esters carrying hydroxyl groups, a process for their preparation and their use
AU576477B2 (en) 5-fluoro-carbacyclins
RO87991A (en) PROCESS FOR THE PREPARATION OF TIAZOLIDIN ESTERS SUBSTITUTED BY MINERAL ACIDS
EP0069049A3 (en) Delta-8,9-prostaglandin derivatives, process for their preparation and their use as medicaments
FI850885L (en) NYA KARBACYKLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
ES8603172A1 (en) New 9-halogen-prostaglandine.